| # | Drug | Count |
|---|---|---|
| 0 | INSULIN GLARGINE | 20 |
| 1 | ADALIMUMAB | 11 |
| 2 | PREDNISONE | 11 |
| 3 | INSULIN ASPART | 10 |
| 4 | INSULIN LISPRO | 9 |
| 5 | MEPOLIZUMAB | 9 |
| 6 | METFORMIN | 9 |
| 7 | METFORMIN ER 500 MG | 9 |
| 8 | METFORMIN ER 750 MG | 9 |
| 9 | ALBUTEROL SULFATE | 8 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | LINAGLIPTIN AND METFORMIN HYDROCHLORIDE | 4 | 0.0032 |
| 1 | PANCRELIPASE LIPASE, PANCRELIPASE AMYLASE, AND PANCRELIPASE PROTEASE | 1 | 0.0015 |
| 2 | DANTROLENE SODIUM | 1 | 0.0009 |
| 3 | METRELEPTIN | 1 | 0.0008 |
| 4 | CHLORZOXAZONE | 1 | 0.0008 |
| 5 | PRAZOSIN HYDROCHLORIDE | 1 | 0.0007 |
| 6 | SENNOSIDES A AND B | 1 | 0.0006 |
| 7 | TERBUTALINE SULFATE | 1 | 0.0005 |
| 8 | INSULIN GLULISINE | 5 | 0.0005 |
| 9 | INSULIN ASPART INJECTION | 1 | 0.0004 |
| # | Drug class | Count |
|---|---|---|
| 0 | Insulin Analog [EPC] | 34 |
| 1 | Corticosteroid [EPC] | 22 |
| 2 | GLP-1 Receptor Agonist [EPC] | 15 |
| 3 | Angiotensin 2 Receptor Blocker [EPC] | 9 |
| 4 | Interleukin-5 Antagonist [EPC] | 9 |
| 5 | Nonsteroidal Anti-inflammatory Drug [EPC] | 8 |
| 6 | Insulin [EPC] | 7 |
| 7 | Kinase Inhibitor [EPC] | 7 |
| 8 | Tumor Necrosis Factor Blocker [EPC] | 7 |
| 9 | Atypical Antipsychotic [EPC] | 6 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 9 | 0.0131 |
| 1 | Leptin Analog [EPC] | 1 | 0.0008 |
| 2 | Plasma Kallikrein Inhibitor [EPC] | 1 | 0.0004 |
| 3 | Tyrosine Kinase 2 Inhibitor [EPC] | 1 | 0.0003 |
| 4 | Progestin Antagonist [EPC] | 1 | 0.0002 |
| 5 | Recombinant Human Growth Hormone [EPC] | 4 | 0.0002 |
| 6 | Non-Standardized Insect Allergenic Extract [EPC] | 1 | 0.0002 |
| 7 | Provitamin D2 Compound [EPC] | 5 | 0.0002 |
| 8 | PCSK9 Inhibitor [EPC] | 4 | 0.0002 |
| 9 | Insulin [EPC] | 7 | 0.0002 |